Ubs Global Asset Management Americas »

Tg Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 162k 15.21
2023-12-31 $2.8M 162k 17.08
2023-09-30 $1.4M 162k 8.36
2023-06-30 $2.0M 134k 15.04
2023-03-31 $2.0M 134k 15.04
2022-12-31 $1.8M 156k 11.83
2022-09-30 $838k 142k 5.92
2022-06-30 $625k 147k 4.25
2022-03-31 $1.4M 146k 9.51
2021-12-31 $2.2M 116k 19.00
2021-09-30 $4.0M 119k 33.28
2021-06-30 $4.4M 112k 38.79
2021-03-31 $5.0M 103k 48.20
2020-12-31 $17M 643k 26.76
2020-09-30 $17M 643k 26.76
2020-06-30 $13M 677k 19.48
2020-03-31 $6.5M 662k 9.84
2019-12-31 $8.1M 732k 11.10
2019-09-30 $3.6M 649k 5.61
2019-06-30 $5.3M 609k 8.65
2019-03-31 $4.8M 594k 8.04
2018-12-31 $2.7M 658k 4.10
2018-09-30 $3.9M 692k 5.60
2018-06-30 $9.2M 697k 13.15
2018-03-31 $14M 951k 14.20
2017-12-31 $8.8M 1.1M 8.20
2017-09-30 $13M 1.1M 11.85
2017-06-30 $11M 1.1M 10.05
2017-03-31 $18M 1.5M 11.65
2016-12-31 $7.2M 1.5M 4.65
2016-09-30 $12M 1.5M 7.74
2016-06-30 $11M 1.8M 6.06
2016-03-31 $17M 2.0M 8.52
2015-12-31 $19M 1.6M 11.93
2015-09-30 $1.6M 156k 10.08
2015-06-30 $265k 16k 16.56
2015-03-31 $183k 12k 15.51